Antares Pharma (AIS)
Antares Pharma Shareholders Equity: 32.09M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AIS Shareholders Equity Rankings
| Overall | 13th percentile | 3802 of 4385 |
| Sector | 30th percentile | 350 of 504 in Healthcare |
| Industry | 23rd percentile | 49 of 64 in Medical Instruments & Supplies |
AIS Shareholders Equity Range, Past 5 Years
| Minimum | 2.891M | Jun 2009 |
| Maximum | 32.09M | Mar 2012 |
| Average | 13.95M |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
You may also be interested in these AIS related companies
AIS News
@ANDISIK try to get timing/Entry better next time $AIS.Over history its proven 2 bounce back,so buy big dips not tops,n you'll luv this name
about 2 hours ago by HighGrowthFinancial
about 2 hours ago by HighGrowthFinancial
@HighGrowthFinancial $AIS is not hard but impossible to predict the price movement. Kills me that I could be making $ elsewhere.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
$AIS not buying this dip just yet, its been bouncing back from sub $3 everytime, not sure about this one though
about 3 days ago by HighGrowthFinancial
about 3 days ago by HighGrowthFinancial
@GPrime, $AIS, Example of making money elsewhere, bought SPPI yesterday at $10.76, its now at $11.20, a 4% gain.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
$AIS, really does test your patience. If it can't hold ~ $2.90, I'm going to start getting out. Buy back when lower or go make $ elsewhere.
about 3 days ago by ANDISIK
about 3 days ago by ANDISIK
RT @casualtrader: Long $AIS Long will run into next earning date $CLSN Celsion buy @ 1,6 ~ 1,8 run up come by end of this year 8$ come
about 4 days ago by BioInvestor
about 4 days ago by BioInvestor
@casualtrader, $AIS. You should check out $SPPI, great company. I actually got back in today. ·
about 4 days ago by ANDISIK
about 4 days ago by ANDISIK
@markf @ANDISIK any other biotech ideas? Long $AIS, looking to initiate long position $ZLCS. Thoughts?
about 4 days ago by casualtrader
about 4 days ago by casualtrader
@markf $AIS not that I'm aware of.Just a safer long term biotech investment with huge potential. Don't need to put all $ in riskier biotechs
about 4 days ago by ANDISIK
about 4 days ago by ANDISIK
On 5/19/12 Columbine Capital Services upgraded $AIS from Neutral to Favorable.
about 6 days ago by ANDISIK
about 6 days ago by ANDISIK
RT @markf: $AIS on Aug 8th..?? on earnings day for $AIS next earning is Aug 7 or 8 2012 positive earning come 100%
about 10 days ago by BioInvestor
about 10 days ago by BioInvestor
Antares Pharma Appoints LeRoux Jooste Senior Vice President Pharmaceutical Sales and Marketing
May 15, 7:00AM Business Wire
May 15, 7:00AM Business Wire
Antares Pharma to Present at the 15th Annual Bank of America Merrill Lynch Health Care Conference
May 10, 7:00AM Business Wire
May 10, 7:00AM Business Wire
Antares Pharma Reports First Quarter 2012 Financial and Operating Results
May 08, 7:00AM Business Wire
May 08, 7:00AM Business Wire
Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva and Pfizer
Apr 26, 9:26AM Business Wire
Apr 26, 9:26AM Business Wire
Watson and Antares Announce the Introduction of Gelnique 3%™, for the Treatment of Overactive Bladder
Apr 26, 7:00AM PR Newswire
Apr 26, 7:00AM PR Newswire
Antares Pharma to Present at the 11th Annual Needham Healthcare Conference
Mar 28, 7:00AM Business Wire
Mar 28, 7:00AM Business Wire
Antares Pharma and Boston Scientific Look to Make Headway in Surging Medical Supplies Industry
Mar 22, 8:20AM Marketwire
Mar 22, 8:20AM Marketwire
Antares Pharma Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
Mar 12, 7:00AM Business Wire
Mar 12, 7:00AM Business Wire
Antares Pharma Appoints John J. Howarth Vice President of Corporate Affairs
Feb 27, 9:30AM Business Wire
Feb 27, 9:30AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AIS | 2.89 | +0.02 | +0.70% | 299.69M |
| AIRT | 9.250 | +0.17 | +1.87% | 22.66M |
| AIRM | 91.97 | -0.12 | -0.13% | 1.159B |
| AIR | 12.48 | -0.29 | -2.27% | 502.69M |
| AIQ | 1.05 | -0.02 | -1.87% | 55.99M |
| AMS | 3.09 | +0.03 | +0.98% | 14.24M |
| AMRS | 2.57 | +0.20 | +8.44% | 144.59M |
| AMRI | 2.71 | -0.05 | -1.81% | 83.39M |
| AMRC | 11.07 | -0.15 | -1.34% | 289.15M |
| AMPL | 0.185 | +0.01 | +2.83% | 10.38M |